Journal
JOURNAL OF MEDICAL GENETICS
Volume 43, Issue 10, Pages 769-787Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jmg.2005.039669
Keywords
-
Categories
Funding
- NIAMS NIH HHS [AR-41135, AR-049698, AR-42044] Funding Source: Medline
Ask authors/readers for more resources
Marfan syndrome ( MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated individuals with MFS is acute aortic dissection, which often follows a period of progressive dilatation of the ascending aorta. Recent research on the molecular physiology of fibrillin and the pathophysiology of MFS and related disorders has changed our understanding of this disorder by demonstrating changes in growth factor signalling and in matrix-cell interactions. The purpose of this review is to provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils. Mutations in FBN1 and other genes found in MFS and related disorders will be discussed, and novel concepts concerning the complex and multiple mechanisms of the pathogenesis of MFS will be explained.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available